BIO-TECHNE CORP's ticker is TECH and the CUSIP is 09073M104. A total of 562 filers reported holding BIO-TECHNE CORP in Q3 2021. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
About BIO-TECHNE CORP
Bio-Techne Corp is a leading provider of innovative life science research tools and diagnostic solutions. The company is headquartered in Minneapolis, Minnesota, and has operations in over 50 countries worldwide. Bio-Techne's products and services are used by researchers and clinicians in a wide range of fields, including cancer research, stem cell research, and immunology.
Bio-Techne's success is due in large part to its commitment to innovation and customer service. The company invests heavily in research and development, and has a team of over 1,000 scientists working to develop new products and technologies. Bio-Techne also has a strong focus on customer service, with a dedicated team of technical support specialists available to assist customers with any questions or issues they may have.
In addition to its research tools and diagnostic solutions, Bio-Techne also has a growing portfolio of clinical diagnostic products. The company's Exosome Diagnostics subsidiary is a leader in the development of liquid biopsy tests for cancer diagnosis and monitoring.
Bio-Techne's leadership team is comprised of experienced executives with a track record of success in the life sciences industry. Charles Kummeth, the company's CEO, has been with Bio-Techne since 2013 and has overseen significant growth and expansion during his tenure.
Overall, Bio-Techne is a company with a strong reputation for innovation, customer service, and leadership in the life sciences industry. With a growing portfolio of products and services, the company is well-positioned for continued success in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $93,145 | -60.0% | 1,300 | -60.7% | 0.01% | -63.6% |
Q1 2024 | $232,780 | +611.5% | 3,307 | +680.0% | 0.02% | +633.3% |
Q4 2023 | $32,716 | -32.6% | 424 | -40.5% | 0.00% | -25.0% |
Q3 2023 | $48,534 | -0.2% | 713 | +19.6% | 0.00% | 0.0% |
Q2 2023 | $48,651 | +149.3% | 596 | +126.6% | 0.00% | +100.0% |
Q1 2023 | $19,512 | +88.3% | 263 | +110.4% | 0.00% | +100.0% |
Q4 2022 | $10,360 | +48.0% | 125 | +380.8% | 0.00% | 0.0% |
Q3 2022 | $7,000 | -22.2% | 26 | +4.0% | 0.00% | 0.0% |
Q2 2022 | $9,000 | -98.3% | 25 | -98.0% | 0.00% | -97.1% |
Q1 2022 | $537,000 | -16.2% | 1,240 | 0.0% | 0.03% | -12.8% |
Q4 2021 | $641,000 | +7.2% | 1,240 | +0.4% | 0.04% | -7.1% |
Q3 2021 | $598,000 | +7.6% | 1,235 | +0.1% | 0.04% | +13.5% |
Q2 2021 | $556,000 | +18.0% | 1,234 | 0.0% | 0.04% | +8.8% |
Q1 2021 | $471,000 | -19.8% | 1,234 | -33.2% | 0.03% | -27.7% |
Q4 2020 | $587,000 | +524.5% | 1,848 | +385.0% | 0.05% | +487.5% |
Q3 2020 | $94,000 | -38.2% | 381 | -33.7% | 0.01% | -33.3% |
Q2 2020 | $152,000 | +42.1% | 575 | +1.8% | 0.01% | +20.0% |
Q1 2020 | $107,000 | -9.3% | 565 | +4.8% | 0.01% | 0.0% |
Q4 2019 | $118,000 | +12.4% | 539 | 0.0% | 0.01% | 0.0% |
Q3 2019 | $105,000 | -6.2% | 539 | +0.2% | 0.01% | -16.7% |
Q2 2019 | $112,000 | +4.7% | 538 | 0.0% | 0.01% | -7.7% |
Q1 2019 | $107,000 | +37.2% | 538 | +0.2% | 0.01% | +18.2% |
Q4 2018 | $78,000 | -29.1% | 537 | 0.0% | 0.01% | -21.4% |
Q3 2018 | $110,000 | +39.2% | 537 | +0.2% | 0.01% | +27.3% |
Q2 2018 | $79,000 | +146.9% | 536 | +149.3% | 0.01% | +175.0% |
Q1 2018 | $32,000 | +14.3% | 215 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $28,000 | – | 215 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 46,500 | $16,119,000 | 8.75% |
Montanaro Asset Management Ltd | 93,950 | $32,567,000 | 4.90% |
Jackson Square Partners, LLC | 556,157 | $192,786,000 | 4.50% |
STONE RUN CAPITAL, LLC | 22,405 | $7,767,000 | 3.91% |
Ownership Capital B.V. | 655,654 | $227,276,000 | 3.90% |
Brown Capital Management | 839,587 | $291,034,000 | 3.90% |
Sandhill Capital Partners LLC | 97,382 | $33,757,000 | 3.61% |
DF DENT & CO INC | 684,026 | $237,111,000 | 3.34% |
Westwind Capital | 27,946 | $9,687,000 | 3.17% |
MAIRS & POWER INC | 655,930 | $227,371,000 | 2.72% |